| Dr Daniel A Rodgers, MD | |
|
4605 Maccorkle Ave Sw, Thomas Memorial Hospital, South Charleston, WV 25309-1311 | |
| (304) 343-4625 | |
| (304) 343-4626 |
| Full Name | Dr Daniel A Rodgers |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 16 Years |
| Location | 4605 Maccorkle Ave Sw, South Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255508644 | NPI | - | NPPES |
| 0440823 | Medicaid | OH | |
| 3810027319 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD448253 (Pennsylvania) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 23872 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Memorial Hospital | South charleston, WV | Hospital |
| St Francis Hospital | Charleston, WV | Hospital |
| Montgomery General Hospital, Inc | Montgomery, WV | Hospital |
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Charleston Surgical Hospital | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montgomery General Hospital, Inc | 6204735269 | 30 |
| Kanawha Valley Radiologists Incorporated | 7618956392 | 9 |
News Archive
Fortunately, our cells contain many enzymes devoted strictly to detecting and repairing any damage caused by these insults. In fact, failure of these enzymes to make needed repairs to genes can lead to the accumulation of mutations and, eventually, cell death or possibly cancer.
Astronauts, submariners, miners, and those suffering from lung ailments take note: Innovation is coming to the rescue. A group of scientists from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
"Look both ways before you cross the street" may be sage advice, but it is also apparently necessary for children as old as 13, according to a new study by Ben-Gurion University of the Negev (BGU) researchers, who have pinpointed many of the behaviors that lead to child pedestrians being hit by cars.
Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.
› Verified 9 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Fortunately, our cells contain many enzymes devoted strictly to detecting and repairing any damage caused by these insults. In fact, failure of these enzymes to make needed repairs to genes can lead to the accumulation of mutations and, eventually, cell death or possibly cancer.
Astronauts, submariners, miners, and those suffering from lung ailments take note: Innovation is coming to the rescue. A group of scientists from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
"Look both ways before you cross the street" may be sage advice, but it is also apparently necessary for children as old as 13, according to a new study by Ben-Gurion University of the Negev (BGU) researchers, who have pinpointed many of the behaviors that lead to child pedestrians being hit by cars.
Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.
› Verified 9 days ago
| Entity Name | Montgomery General Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619913647 PECOS PAC ID: 6204735269 Enrollment ID: O20040108000241 |
News Archive
Fortunately, our cells contain many enzymes devoted strictly to detecting and repairing any damage caused by these insults. In fact, failure of these enzymes to make needed repairs to genes can lead to the accumulation of mutations and, eventually, cell death or possibly cancer.
Astronauts, submariners, miners, and those suffering from lung ailments take note: Innovation is coming to the rescue. A group of scientists from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
"Look both ways before you cross the street" may be sage advice, but it is also apparently necessary for children as old as 13, according to a new study by Ben-Gurion University of the Negev (BGU) researchers, who have pinpointed many of the behaviors that lead to child pedestrians being hit by cars.
Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.
› Verified 9 days ago
| Entity Name | Kanawha Valley Radiologists Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609975630 PECOS PAC ID: 7618956392 Enrollment ID: O20040715001465 |
News Archive
Fortunately, our cells contain many enzymes devoted strictly to detecting and repairing any damage caused by these insults. In fact, failure of these enzymes to make needed repairs to genes can lead to the accumulation of mutations and, eventually, cell death or possibly cancer.
Astronauts, submariners, miners, and those suffering from lung ailments take note: Innovation is coming to the rescue. A group of scientists from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
"Look both ways before you cross the street" may be sage advice, but it is also apparently necessary for children as old as 13, according to a new study by Ben-Gurion University of the Negev (BGU) researchers, who have pinpointed many of the behaviors that lead to child pedestrians being hit by cars.
Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel A Rodgers, MD Po Box 840, Lima, OH 45802-0840 Ph: (877) 574-7116 | Dr Daniel A Rodgers, MD 4605 Maccorkle Ave Sw, Thomas Memorial Hospital, South Charleston, WV 25309-1311 Ph: (304) 343-4625 |
News Archive
Fortunately, our cells contain many enzymes devoted strictly to detecting and repairing any damage caused by these insults. In fact, failure of these enzymes to make needed repairs to genes can lead to the accumulation of mutations and, eventually, cell death or possibly cancer.
Astronauts, submariners, miners, and those suffering from lung ailments take note: Innovation is coming to the rescue. A group of scientists from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
"Look both ways before you cross the street" may be sage advice, but it is also apparently necessary for children as old as 13, according to a new study by Ben-Gurion University of the Negev (BGU) researchers, who have pinpointed many of the behaviors that lead to child pedestrians being hit by cars.
Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.
› Verified 9 days ago
Robert Smith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 416 Division St, South Charleston, WV 25309 Phone: 304-766-7141 Fax: 304-766-7143 | |
Dr. Patrick E. Hill, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4605 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-766-3600 Fax: 304-343-4626 | |
David Abramowitz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4605 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-766-3600 Fax: 304-343-4626 | |
Lyubov Girshovich, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4605 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-766-7668 | |
Jose Paras Barba, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4605 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-766-3668 Fax: 304-766-5654 | |
Tara Melgary Hansen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 401 Division St, South Charleston, WV 25309 Phone: 304-766-3413 Fax: 304-766-5654 |